Search

everythinglearnresearchcommunity

for

Search:↓

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

EGFR inhibitors can cause unusual localized hair growth.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Men's skincare products with essential oils can improve skin health and may increase male interest in cosmetics.

The document explains various skin conditions and their treatments.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Erlotinib may cause scarring hair loss.

Eating high glycemic foods and drinking milk may worsen acne by increasing insulin and IGF-1 levels.

Eating nuts, chocolate candy, and red tea might worsen acne, while eating more fresh vegetables could reduce it.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Increased FGFR2b signaling, influenced by androgens, plays a role in causing acne.

Meibomian glands are highly specialized and differ significantly from other sebaceous glands in structure and function.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Removing Gsdma1/2/3 genes reduces skin cell overgrowth by blocking a specific cell pathway.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

A genetic variant in "Blonde d'Aquitaine" calves causes death at birth due to a missing protein.

Fumai Paste helps heal skin damage from chemotherapy better than magnesium sulfate.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Targeting EGFR may help reduce hair loss from chemotherapy.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.